yes it is all very strange - falling on extremely low volume and trading just 50 cents from its 52 week low.My estimate it's a buy - $5.25 presents significant upside.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%